•
Sep 30, 2015

EyePoint Pharmaceuticals Q1 2016 Earnings Report

Total Revenue
$466K
Previous year: $25.3M
-98.2%
EPS
-$1.7
Previous year: $6.7
-125.4%
Gross Profit
-$3.02M
Previous year: $22.5M
-113.4%
Cash and Equivalents
$14.1M
Previous year: $11.4M
+23.8%
Total Assets
$27.5M
Previous year: $43.7M
-37.2%

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals